India News4 years ago
Centre’s Covid panel recommends new protocols, increases Covishield dose gap to 12-16 weeks
The Hyderabad-based Bharat Biotech's indigenously developed Covaxin and Oxford-AstraZeneca's Covishield are currently being used in India's inoculation drive against coronavirus.